Ubs Group Ag Ac Immune Sa Transaction History
Ubs Group Ag
- $397 Billion
- Q1 2024
A detailed history of Ubs Group Ag transactions in Ac Immune Sa stock. As of the latest transaction made, Ubs Group Ag holds 23,665 shares of ACIU stock, worth $110,042. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,665
Previous 45,000
47.41%
Holding current value
$110,042
Previous $225,000
68.89%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding ACIU
# of Institutions
41Shares Held
29MCall Options Held
92.9KPut Options Held
46.3K-
Bvf Inc San Francisco, CA14.6MShares$67.8 Million1.29% of portfolio
-
Avidity Partners Management LP Dallas, TX4.47MShares$20.8 Million0.51% of portfolio
-
Black Rock Inc. New York, NY2.54MShares$11.8 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA2.01MShares$9.33 Million0.23% of portfolio
-
Morgan Stanley New York, NY1.38MShares$6.43 Million0.0% of portfolio
About AC Immune SA
- Ticker ACIU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,413,504
- Market Cap $388M
- Description
- AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...